BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 26, 2015
Insider Transaction Report
Form 4
Schamroth Michael
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2015-08-24−24,000→ 0 totalExercise: $4.00Exp: 2017-03-01→ Common Stock, $0.001 par value (24,000 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2015-08-24$4.00/sh+24,000$96,000→ 54,000 total
Footnotes (1)
- [F1]The option was granted on March 2, 2007 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.